Those following along with Bruker Corporation (NASDAQ:BRKR) will no doubt be intrigued by the recent purchase of shares by Frank Laukien, Chairman of the company, who spent a stonking US$1.0m on ...

Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the ...

Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the Bruker ...

Frank Laukien, President and CEO, reported that Bruker achieved Q4 2024 constant exchange rate (CER) revenue growth of 15.8%, with reported revenues reaching $979.6 million and organic growth of 3.9%.

My name is Joe Kostka, and I'm the Director of Bruker Investor Relations. Joining me on today's call are Frank Laukien, our President and CEO; and Gerald Herman, our EVP and CFO. In addition to ...

Reports Q4 revenue $979.6M, consensus $965.61M. Frank Laukien, Bruker’s (BRKR) president and CEO, commented: “The year 2024 was transformational for Bruker. We completed several strategic ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

FRANK H LAUKIEN, the PRESIDENT & CEO of $BRKR, bought 6,937 shares of the company on 02-18-2025 for an estimated $355,382. This trade was reported by Quiver ...

What gives you confidence in the instrumentation sales? Is it ELITech, AI, aftermarket service, or European offsets? A: Frank Laukien, CEO: There are multiple growth drivers outside the U.S., ...

(1) We define the term acquisitions and divestitures revenue as GAAP revenue from M&A activities excluding the effect of changes in foreign currency translation rates. (2) We define the term ...